Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 2,429,300 | 3,128,200 | 3,503,800 | 3,329,500 | 2,925,700 |
| Cost of Goods | 1,975,300 | 2,414,600 | 2,752,900 | 2,669,600 | 2,312,100 |
| Gross Profit | 454,000 | 713,600 | 750,900 | 659,900 | 613,600 |
| Operating Expenses | 438,800 | 846,600 | 427,700 | 355,100 | 451,600 |
| Operating Income | 15,500 | -132,400 | 324,100 | 305,400 | 162,100 |
| Interest Expense | 24,200 | 35,200 | 41,900 | 55,500 | 80,000 |
| Other Income | -10,800 | 5,900 | 1,800 | 15,900 | -37,000 |
| Pre-tax Income | -19,500 | -161,700 | 284,000 | 265,800 | 45,100 |
| Income Tax | -8,900 | 43,600 | 76,700 | 69,400 | -13,800 |
| Net Income Continuous | -10,600 | -205,300 | 207,300 | 196,400 | 58,900 |
| Net Income Discontinuous | 9,700 | 8,300 | N/A | N/A | 1,200 |
| Minority Interests | 1,600 | 1,800 | 800 | N/A | N/A |
| Net Income | $-2,500 | $-198,800 | $206,500 | $195,200 | $60,100 |
| EPS Basic Total Ops | -0.03 | -2.08 | 2.15 | 2.06 | 0.67 |
| EPS Basic Continuous Ops | -0.13 | -2.17 | 2.15 | 2.07 | 0.65 |
| EPS Basic Discontinuous Ops | 0.10 | 0.09 | N/A | N/A | 0.02 |
| EPS Diluted Total Ops | -0.03 | -2.08 | 2.10 | 2.01 | 0.65 |
| EPS Diluted Continuous Ops | -0.13 | -2.17 | 2.11 | 2.02 | 0.64 |
| EPS Diluted Discontinuous Ops | 0.10 | 0.09 | N/A | N/A | 0.01 |
| EBITDA(a) | $174,800 | $6,800 | $469,700 | $458,200 | $330,200 |